Caliper Life Sciences, Inc. has launched Caliper Discovery Alliances & Services (CDAS), a new organization created from Caliper’s acquisition of NovaScreen Biosciences, a provider of in vitro discovery services, and Xenogen Biosciences, a provider of in vivo discovery services. NovaScreen was acquired in October 2005 and Xenogen was acquired in August 2006. Caliper’s strategy is to provide its customers with the tools for building an “In Vitro-In Vivo Bridge” to ...